Dr. Colwyn “CoCo” Headley is a distinguished Postdoctoral Fellow at Stanford University, is known for his research focusing on aging-associated mitochondrial dysfunction and immunity. Conducting research under the mentorship of Dr. Philip Tsao, he blends his deep interest in mitochondrial dysfunction and immunity with Dr. Tsao’s expertise in cardiovascular disease. By drawing on Dr. Tsao’s expertise, Dr. Headley enhances our understanding of the immune-cardiovascular axis, bridging key areas of study. A key area of his research is to reveal novel perspectives on how the immune system interacts with cardiovascular health as we age.
Dr. Headley earned his B.S. in Microbiology and later completed his Ph.D. in Biomedical Sciences with a focus on Immunology, both at The Ohio State University. During his doctoral research in Dr. Joanne Turner’s lab, he explored the impact of biological aging on adaptive immunity, examining how aging influences immune responses and identifying potential strategies to boost immune function in older adults.
Known for his innovative research in longevity and mitochondrial health, Dr. Headley’s contributions are widely recognized in the scientific community. His newly published paper ‘Mitochondrial Replacement Therapy to Treat Aging-associated Immune Dysregulations’ has been celebrated as a groundbreaking study that explores new ways to treat immune dysfunction in aging. His work continues to push boundaries in the fields of immunity and cardiovascular health, offering promising insights to pave the way for new treatments.
